{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:03:06Z","timestamp":1790352186116,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The diagnosis of Myelodysplastic syndromes (MDS) is frequently challenging, especially in terms of the distinction from the other non-neoplastic causes of cytopenia. Currently, it is based on the presence of peripheral blood cytopenias, peripheral blood and bone marrow dysplasia\/blasts, and clonal cytogenetic abnormalities, but MDS diagnostic features are polymorphic and non-specific. We investigated the utility of complete blood count (CBC) and research parameters (RUO) from the analyzer BC 6800 Plus (Mindray Diagnostics) to discriminate MDS-related cytopenia. Methods: 100 samples from healthy individuals were used to establish the values of research parameters in normal subjects. A retrospective study was conducted including 66 patients diagnosed with MDS, 90 cytopenic patients due to other diseases (cancer patients receiving therapy, aplastic anemia, other hematological malignancies) and 50 with macrocytic anemia. The Wilcoxon test was applied to detect statistical differences among the groups of patients, considering p &lt; 0.05 significant. The diagnostic performance of the RUO parameters for discriminating MDS among cytopenias was evaluated using receiver operating characteristic (ROC) curve analysis. Amultivariable logistic regression model was performed to identify the potential predictors for having MDS. The area under curve (AUC) and the Hosmer\u2013Lemeshow test of the model were assessed. The performance of the model was verified in a prospective study including 224 cytopenic patients (validation group). Results: In the MDS group, the mean cell volume (MCV), percentage of macrocytic red cells (MAC), red cell distribution width (RDW) and immature platelets fraction (IPF) had increased values compared to the cytopenic and normal patients, while platelets, red and white cell counts, Neu X (related to the cytoplasmic complexity of neutrophils), Neu Y (related to nucleic acid content) and Neu Z (related to cell size) were lower (p &lt; 0.001). Neu X, Neu Y, and Neu Z showed higher AUC for detecting MDS &gt; 0.80; MAC, RDW and IPF AUC &gt; 0.76. The multivariable model demonstrated that Neu X and Neu Y could be used in the recognition of MDS, AUC 0.88. In the validation group, 89.0% of the MDS patients were well classified. Conclusion: MDS are common malignant disorders with a poor prognosis, and early diagnosis is warranted for optimal benefit from treatment. RUO gain insights to detect dysplasia of MDS and could be used in the differential diagnosis of MDS from cytopenias of other etiologies.<\/jats:p>","DOI":"10.3390\/diagnostics14131322","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T08:50:08Z","timestamp":1718959808000},"page":"1322","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complete Blood Counts and Research Parameters in the Detection of Myelodysplastic Syndromes"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-7392","authenticated-orcid":false,"given":"Elo\u00edsa","family":"Urrechaga","sequence":"first","affiliation":[{"name":"Laboratory, Galdakao-Usansolo Hospital, 48960 Galdakao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Hematology, Hospital Universitario Araba, 01009 Vitoria-Gasteiz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-3030","authenticated-orcid":false,"given":"Urko","family":"Aguirre","sequence":"additional","affiliation":[{"name":"Research Unit, Osakidetza Basque Health Service, Barrualde-Galdakao Integrated Health Organisation, Galdakao-Usansolo Hospital, 48960 Galdakao, Spain"},{"name":"Kronikgune Institute for Health Services Research, 48902 Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes: A Review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","year":"2023","journal-title":"Am. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.amjmed.2012.04.017","article-title":"Why are myelodysplastic syndromes unrecognized and underdiagnosed? A primary care perspective","volume":"125","author":"Khan","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ijlh.12933","article-title":"Hidden myelodysplastic syndrome(MDS): A prospective study to confirm or exclude MDS inpatients with anemia of uncertain etiology","volume":"41","author":"Bastida","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Fenaux","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_6","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhu, J., Clauser, S., Freynet, N., and Bardet, V. (2022). Automated Detection of Dysplasia: Data Mining from Our Hematology Analyzers. Diagnostics, 12.","DOI":"10.3390\/diagnostics12071556"},{"key":"ref_9","unstructured":"BC-6800 Plus Auto Hematology Analyzer (2018). Operator\u2019s Manual, Mindray Bio-medical Electronics Co., Ltd."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ijlh.14057","article-title":"Combination of NeuX and NeuZ can predict neutrophil dysplasia features of myelodysplastic neoplasms in peripheral blood","volume":"45","author":"Sun","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-022-00402-5","article-title":"Myelodysplastic syndromes","volume":"8","author":"Li","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ijlh.13607","article-title":"How I investigate dysgranulopoiesis","volume":"43","author":"Shekhar","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1751-553X.2009.01194.x","article-title":"The utility of the Sysmex XE-2100 analyzer\u2019s NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes","volume":"32","author":"Furundarena","year":"2010","journal-title":"Int. J. Lab. Hem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/ijlh.12285","article-title":"Picking up myelodysplastic syndromes and megaloblastic anemias on peripheral blood: Use of NEUT-X and NEUT-Y in guiding smear reviews","volume":"37","author":"Goel","year":"2015","journal-title":"Int. J. Lab. Hem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/ijlh.13361","article-title":"Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer","volume":"43","author":"Kim","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/ijlh.13779","article-title":"Cell population data from Sysmex XN analyzer and myelodysplastic syndrome","volume":"44","author":"Murphy","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_17","first-page":"e40","article-title":"Cell Population Data NE-WX, NE-FSC, LY-Y of Sysmex XN-9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study","volume":"44","author":"Giannotta","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kwiecie\u0144, I., Rutkowska, E., Gawro\u0144ski, K., Kulik, K., Dudzik, A., Zakrzewska, A., Raniszewska, A., Sawicki, W., and Rzepecki, P. (2023). Usefulness of New Neutrophil-Related Hematologic Parameters in Patients with Myelodysplastic Syndrome. Cancers, 15.","DOI":"10.3390\/cancers15092488"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/bjh.15626","article-title":"A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients","volume":"183","author":"Boutault","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jclinpath-2021-207860","article-title":"Beyond the routine CBC: Machine learning and statistical analyses identify research CBC parameter associations with myelodysplastic syndromes and specific underlying pathogenic variants","volume":"76","author":"Pozdnyakova","year":"2023","journal-title":"J. Clin. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ajh.23643","article-title":"Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters","volume":"89","author":"Raess","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cca.2018.01.029","article-title":"Discriminating myelodysplastic syndrome and other myeloid malignancies from non-clonal disorders by multiparametric analysis of automated cell data","volume":"480","author":"Kim","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ravalet, N., Foucault, A., Picou, F., Gombert, M., Renoult, E., Lejeune, J., Vallet, N., Lachot, S., Rault, E., and Gyan, E. (2021). Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman\u2013Coulter DxH 800 Hematology Analyzer. Cancers, 13.","DOI":"10.3390\/cancers13030389"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ijlh.13777","article-title":"Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia","volume":"44","author":"Hwang","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/dx-2016-0011","article-title":"Assessment of reticulated platelets with automated hemocytometers: Are we measuring the same thing?","volume":"3","author":"Dima","year":"2016","journal-title":"Diagnosis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2004.04987.x","article-title":"Assessment of an immature platelet fraction IPF in peripheral thrombocytopenia","volume":"126","author":"Briggs","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1515\/cclm-2018-0784","article-title":"Evaluation of Immature Platelet Fraction in Patients with Myelodysplastic Syndromes. Association with Poor Prognosis Factors","volume":"57","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_28","first-page":"54","article-title":"Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: A marker of karyotypic abnormalities associated with poor prognosis","volume":"82","author":"Sugimori","year":"2019","journal-title":"J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.seminhematol.2015.06.002","article-title":"Anemia as the Main Manifestation of Myelodysplastic Syndromes","volume":"52","author":"Santini","year":"2015","journal-title":"Semin. Hematol."},{"key":"ref_30","first-page":"e237","article-title":"Routine diagnostic procedures of myelodysplastic syndromes: Value of a structural blood cell parameter (NEUT-X) determined by the Sysmex XE-2100","volume":"32","author":"Vlad","year":"2010","journal-title":"Int. J. Lab. Hem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12185-011-0892-x","article-title":"Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome","volume":"94","author":"Inaba","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cyto.b.21947","article-title":"Automated leukocyte parameters are useful in the assessment of myelodysplastic syndromes","volume":"100","author":"Shestakova","year":"2021","journal-title":"Cytometry B Clin. Cytom."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1322\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:02:31Z","timestamp":1760108551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":32,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14131322"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14131322","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}